Indication of the extent of hepatectomy for hepatocellular carcinoma on cirrhosis by a simple algorithm based on preoperative variables

Arch Surg. 2009 Jan;144(1):57-63; discussion 63. doi: 10.1001/archsurg.2008.522.

Abstract

Objective: To produce a model indicating the extent of hepatectomy for hepatocellular carcinoma on cirrhosis based on easily available preoperative data.

Design: Retrospective study based on multicenter prospectively updated databases.

Setting: Two tertiary referral centers specializing in hepatobiliary surgery.

Patients: A total of 466 patients undergoing hepatectomy for hepatocellular carcinoma on cirrhosis between 1995 and 2006.

Main outcome measures: To create a decision tree for safe liver resection based on factors affecting irreversible postoperative liver failure (IPLF).

Results: A total of 23 patients (4.9%) developed IPLF. The model for end-stage liver disease (MELD) score (categorized as <9, 9-10, and >10; P < .05 for all comparisons) and extent of hepatectomy were independent predictors of IPLF. In patients with a MELD score of less than 9, the IPLF rate was 0.4%. In patients with a MELD score of 9 or 10, the IPLF rate was 1.2% for resections of less than 1 segment, 5.1% for segmentectomies or bisegmentectomies, and 11.1% for major hepatectomies. In this category of MELD, serum sodium levels identified a low-risk group (sodium > or =140 mEq/L; to convert to millimoles per liter, multiply by 1.0) not experiencing IPLF and a high-risk group (sodium <140 mEq/L) in which resections of less than 1 segment led to an IPLF rate of 2.5% and resections of 1 segment or more led to an IPLF rate of more than 5% (P < .05). In patients with a MELD score of more than 10, the IPLF rate was more than 15% in all types of hepatectomies.

Conclusion: A simple algorithm based on the MELD score and serum sodium level can indicate the maximum tolerable extent of hepatectomy for hepatocellular carcinoma on cirrhosis.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Algorithms*
  • Carcinoma, Hepatocellular / complications*
  • Carcinoma, Hepatocellular / surgery*
  • Female
  • Hepatectomy / adverse effects
  • Hepatectomy / methods*
  • Humans
  • Liver Cirrhosis / complications*
  • Liver Failure / epidemiology
  • Liver Neoplasms / complications*
  • Liver Neoplasms / surgery*
  • Male
  • Middle Aged
  • Models, Statistical
  • Postoperative Complications / epidemiology
  • Retrospective Studies
  • Young Adult